http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-780952-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 1978-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-780952-L
titleOfInvention Phenylamino-phenylacetic acid amides
abstract Phenylacetic acid amide compounds of the formula <IMAGE> (I) in which R1 is hydrogen, lower alkyl, lower alkoxy, halogen having an atomic number of not more than 35 or trifluoromethyl, R2 is hydrogen, lower alkyl, lower alkoxy, halogen having an atomic number of not more than 35 or trifluoromethyl, R3 is hydrogen, lower alkyl, lower alkoxy or halogen having an atomic number of not more than 35 and R4 is hydrogen, lower alkyl, lower alkoxy or halogen having an atomic number of not more than 35, and in which R5 is a radical of aliphatic character containing the group R6, R6 and R7 are each hydrogen or together are a divalent aliphatic radical and the group of the formula -C(=O)-R8 (Ia) is a carboxyl group, which can be functionally modified, and their salts are useful as anti-inflammatory agents.n[US4420490A]
priorityDate 1977-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4158943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421015623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 43.